Redica Systems, a leader in Quality and Regulatory Intelligence for the Life Sciences industry, announced a financing. Merck Global Health Innovation Fund (MGHIF), along with existing investors Savant Growth and Rock Creek Capital, participated in the financing.
This partnership enhances Redica’s strong foundation for extracting, enriching, and connecting unstructured data—from regulations and standards to inspections and enforcement—transforming it into structured, actionable intelligence.
What the funding will be used for: The funding will advance Redica’s expansion of its Catalyst Platform and the Redica Supplier Data Network (SDN), enhancing AI-driven workflows, predictive quality and regulatory intelligence, and supply chain risk management solutions tailored for life sciences organizations.
Redica Catalyst Platform: Redica Catalyst Platform is a purpose-built Enterprise AI regulatory and quality solution for the Life Sciences sector. And it uses a multilayered architecture to integrate structured and unstructured data from public and private sources. And with capabilities such as Redica ID – for entity resolution and integration with master data and Redica DocIQ – for processing unstructured data, Catalyst supports predictive quality, compliance, and supply chain oversight with precision and scale. It uniquely blends AI with human-in-the-loop workflows to ensure high data accuracy, actionable insights, and seamless enterprise adoption.
Redica Supplier Data Network (SDN): Redica Supplier Data Network (SDN) is a transformative data-sharing ecosystem designed to resolve persistent challenges around fragmented supplier risk data. It consolidates proprietary and public datasets to create secure, comprehensive supplier profiles. These profiles integrate seamlessly with Redica ID and feed into the Catalyst engine, powering predictive analytics across the supply chain. Features include shared audit programs, GMP document repositories, and standardized supplier questionnaires—all hosted in a secure environment that promotes cross-enterprise collaboration and reduces redundancy.
KEY QUOTES:
“This investment strengthens our ability to power predictive quality and data-driven AI programs. Our mission is to empower customers to proactively enhance quality and minimize compliance risks—ultimately improving product safety and driving measurable business performance.”
Michael de la Torre, CEO of Redica Systems
“We are excited to work with Redica Systems to advance their groundbreaking work in predictive intelligence. The ability to securely integrate public and private data is an important piece in the life sciences industry’s capacity to monitor and mitigate quality and supply chain risks.”
Joe Volpe, Managing Director at Merck Global Health Innovation Fund
